leader aspirin
- Product NDC
- 70000-0420
- 11-digit product format
- 700000420
- Labeler code
- 70000
- Product ID
- 70000-0420_1b193ded-2e7a-460a-809b-1a2618b28ff3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Labeler
- Cardinal Health 110, LLC. dba Leader
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-08-13
- Substance
- ASPIRIN
- Active strength
- 81 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70000-0420 | 70000-0420-2 | D | Discontinued by firm | 2026-11-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- leader aspirin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 81 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 318272 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b8cc9f78-a292-40eb-819d-bd80a552628f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0420-1 | leader aspirin | 1 in 1 CARTON | TABLET, CHEWABLE | 1 | 4 | |
| 70000-0420-1 | leader aspirin | 36 in 1 BOTTLE | TABLET, CHEWABLE | 36 | 4 | |
| 70000-0420-2 | leader aspirin | 3 in 1 CARTON | TABLET, CHEWABLE | 3 | 4 | |
| 70000-0420-2 | leader aspirin | 36 in 1 BOTTLE | TABLET, CHEWABLE | 36 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0420-1 | EA - Each | 70000-0420 | 4fad3b9d-352e-4440-83fe-7be248874013 | 1 | 2019-02-13 |
| 70000-0420-2 | EA - Each | 70000-0420 | 979b8e63-7434-4405-9245-b96c867f0558 | 1 | 2019-02-13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0420 | LEADER ASPIRIN (ASPIRIN) TABLET, CHEWABLE [CARDINAL HEALTH 110, LLC. DBA LEADER] | 4 | Current NDC, Legacy NDC, 4 package rows | 20240913_b8cc9f78-a292-40eb-819d-bd80a552628f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GeriCare Liquid Pain Relief | ACETAMINOPHEN | Geri-Care Pharmaceuticals, Corp | 85a074da-14b7-4db5-9d47-8ad19f520721 | 2025-01-06 | Warnings | M013 |
| Headache, Circle K | ACETAMINOPHEN, CAFFEINE, ASPIRIN TABLET | Lil' Drug Store Products, Inc. | e711ff0a-2fa0-1f2a-e053-2a95a90a4e38 | 2024-12-31 | Warnings | M013 |
| Extra Strength Headache, Lil Drug Store | EXTRA STRENGHT HEADACHE RELIEF- ACETAMINOPHEN, ASPIRIN, CAFFEINE TABLET | Lil' Drug Store Products, Inc. | 0c41deda-490b-f5d2-e063-6394a90a5047 | 2024-12-31 | Warnings | M013 |
| Extra Strength Headache, Circle K | ACETAMINOPHEN/ASPIRIN/CAFFEINE TABLET | Lil' Drug Store Products, Inc. | d18e1631-de43-4b29-e053-2995a90af56d | 2024-12-31 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN 500 MG, FILM-COATED TABLET | Lil' Drug Store Products, Inc. | e5f9def4-4cf5-4e06-e053-2995a90a07ea | 2024-12-31 | Warnings | M013 |
| Regular Strength Pain Relief | ACETAMINOPHEN | Geri-Care Pharmaceutical Corp | 6158e954-32d8-4718-e053-2a91aa0a27f3 | 2024-12-31 | Warnings | M013 |
| Aspirin | ASPIRIN | Advanced Rx Pharmacy of Tennessee, LLC | f8375029-e567-c6a5-e053-6394a90a5b67 | 2024-12-31 | Warnings | M013 |
| Extra Strength Headache Relief | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Dollar General | 4907056d-6013-46b1-ae86-469dc3001591 | 2024-12-31 | Warnings | M013 |
| Pediacare Childrens Grape | ACETAMINOPHEN | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | f9d531a2-234c-4feb-8f05-212dbee83dfe | 2024-12-30 | Warnings | M013 |
| Pediacare Childrens Acetaminophen Grape | ACETAMINOPHEN | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | 596372c7-eca3-4527-8e22-ab0751e2526b | 2024-12-30 | Warnings | M013 |
| Bayer Genuine Aspirin | BAYER GENUINE ASPIRIN | Lil' Drug Store Products, Inc. | d17834d7-cb3e-6bf2-e053-2a95a90ae5c1 | 2024-12-30 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN 500 MG, FILM-COATED CAPLET | Lil' Drug Store Products, Inc. | e5fd2b46-683e-4cf5-e053-2995a90a5512 | 2024-12-30 | Warnings | M013 |
| Night Time Severe Cold and Cough Relief | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Chain Drug Consortium, LLC | c8e9b57b-83e9-46c5-9791-02c4c2b94004 | 2024-12-29 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC. | 1608b4f0-bf20-4024-b8f2-20a4df7a4b21 | 2024-12-26 | Warnings | M013 |
| Aspirin | ASPIRIN | Advance Pharmaceutical Inc. | f6a9ea44-08b8-4a33-bfbd-68cb2d852c39 | 2024-12-26 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | cfc7eac3-35be-4002-b8ef-be1dfc8caf69 | 2024-12-26 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | a3031139-4709-43f2-95a8-89840c595f7f | 2024-12-26 | Warnings | M013 |
| Acetaminophen 250mg Aspirin 250mg Caffeine 65mg | ACETAMINOPHEN 250MG ASPIRIN 250MG CAFFEINE 65MG | WALGREENS CO. | 98bb28ed-d146-ca3d-e053-2a95a90a9eaf | 2024-12-26 | Warnings | M013 |
| Acetaminophen 500mg Caffeine 60mg Pyrilamine maleate 15mg | ACETAMINOPHEN 500MG CAFFEINE 60MG PYRILAMINE MALEATE 15MG | WALGREENS CO. | 982faa74-d498-cd1e-e053-2995a90afa1e | 2024-12-25 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | AptaPharma Inc. | 11bf6e1b-aed9-4f8f-9f03-ea911ae9f702 | 2024-12-23 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 318272 | aspirin 81 MG Chewable Tablet | PSN | b8cc9f78-a292-40eb-819d-bd80a552628f | 4 |
| 318272 | aspirin 81 MG Chewable Tablet | SCD | b8cc9f78-a292-40eb-819d-bd80a552628f | 4 |
| 318272 | ASA 81 MG Chewable Tablet | SY | b8cc9f78-a292-40eb-819d-bd80a552628f | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70000-0420-1 | 70000042001 | 1 BOTTLE in 1 CARTON (70000-0420-1) / 36 TABLET, CHEWABLE in 1 BOTTLE | 1 bottle | 2018-08-13 | 0000-00-00 | No | No | Current |
| 70000-0420-2 | 70000042002 | 3 BOTTLE in 1 CARTON (70000-0420-2) > 36 TABLET, CHEWABLE in 1 BOTTLE | 3 bottle | 2018-08-13 | 0000-00-00 | No | No | Current |